From lifestyle medicine to AI-powered care, Morrow’s founders explain how longevity could move beyond elite clinics.
Longevity has a branding problem. That’s a hard pill to swallow. For many people, it still conjures images of exclusive clinics, endless biomarker panels and concierge doctors catering to a small, affluent few. The science may be promising, but the experience often feels distant. Something happening over there, for other people.
That tension is being addressed in the latest episode of Longevity.Technology UNLOCKED, where host Phil Newman speaks with Allen Law, founder and CEO of Morrow, and Dr William Tan, Morrow’s Clinical Governance Officer. Together, they explore a deceptively simple question: can longevity be designed as a system, and can that system work for more than just the top one percent?
For Law, the idea didn’t come from medicine at first. It came from running hotels, gyms, yoga studios and strength-training spaces. “We kind of know these are good for the human body,” he says, referring to exercise, movement, and recovery practices. “But more often than not, there is no direct data to back it up.” You feel calmer after yoga, stronger after training, but the feedback loop often ends with intuition.
What bothered Law wasn’t the lack of wellness options, but the lack of connection between lifestyle and measurable health outcomes. “The missing gap for me is the data linkage, the cost and effect,” he explains.
Morrow emerged from that gap, aiming to link everyday behaviors to biomarkers and translate those signals into practical medical guidance. Think of it less like a luxury tune-up and more like a dashboard, showing what’s actually happening under the hood as you live your life.
That philosophy rests on what Law calls lifestyle medicine, built around six pillars: diet, physical activity, stress management, restorative sleep, avoiding harmful substances and social connection.
“If we practice these six areas in a positive manner, we would see a positive impact on our healthspan,” he says. Healthspan, here, is about staying functional, energetic and independent as we age.
Tan’s story gives that idea emotional weight. A physician and neuroscientist, he has lived with paralysis since the age of two after missing a polio vaccination. “I became paralyzed at the age of two,” he recounts. “I grew up with a disability, and I’ve always been ill… claiming hospitals all the time.” His health trajectory only changed when he found sport, eventually becoming a Paralympian.
That experience change how he thinks about medicine. “My big task is to help people not get to the clinics and the hospital,” Tan says. “We don’t want them to come to clinics, to come to the hospital at all.” Instead, he argues, healthcare should focus on keeping people well in their daily lives, long before disease demands attention. It’s the difference between maintaining a building and constantly repairing it after something breaks.
The hardest part of that vision, however, is access. Longevity clinics around the world tend to be expensive by design, Law notes, serving “the first one to five percent of the population.” Morrow set out to challenge that assumption. “Internally, we call it, let’s try to democratize longevity,” he says. That meant starting with the realities of time and money faced by Singapore’s median-income households, not idealized patients with unlimited resources.
One response has been to rethink both testing and staffing. Rather than running hundreds of biomarkers with unclear next steps, Morrow focuses on diagnostics that lead to specific, actionable decisions. And instead of relying entirely on scarce physician time, the clinic is integrating AI systems to handle routine questions and monitoring – while keeping clinicians firmly in control. Law describes this as a “human in the loop” model, where doctors still review and approve medical recommendations.
“How can AI help increase the productivity of these expensive time-cost individuals?” Law asks. The goal isn’t to replace doctors, but to let them care for more people without diluting quality.
What emerges from the conversation is a vision of longevity that feels infrastructural rather than indulgent. No shortcuts; just better-designed systems that align science, behavior and daily life. If longevity is going to matter at a population level, it may need to look less like a luxury product and more like good public design.
Join us every Monday on Longevity.Technology UNLOCKED for in-depth conversations on the future of longevity. Our weekly news roundup arrives each Friday. Stream our podcast on Apple Podcasts, Spotify and YouTube.
READ MORE: Allen Law aims to democratize healthspan through Longevity World
